| 영문 | oxygen | 한글 | 산소 |
|---|---|---|---|
| 설명 | 폐로 들어가 모세혈관을 통해 적혈구내로 들어간다. 적혈구내의 혈색소의 역할로 신체내 모든 조직세포에 전해지며, 인체대사작용에 필수적인 기체이다. |
||
| ICC | immunocompetent cells; immunocytochemistry; Indian childhood cirrhosis; intensive coronary care; int... |
|---|---|
| QO2 | oxygen quotient; oxygen utilization |
| Kd | dissociation constant; distribution coefficient; partition coefficient |
| AOU | apparent oxygen utilization |
| MO2 | myocardial oxygen [utilization] |
| CGU | Cerebral glucose utilization |
|---|---|
| DUR | Drug Utilization Review |
| GUSTO-I | Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries |
| GU | Glucose utilization |
| NMCUES | National Medical Care Utilization and Expenditure Survey |
| oxygen utilization coefficient | The extraction coefficient for oxygen in any given tissue. (05 Mar 2000) |
|---|---|
| carbohydrate utilization test | A test for the definitive identification of clinically important yeasts and yeastlike organisms. (05 Mar 2000) |
| drug utilization | The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles. (12 Dec 1998) |
| drug utilization review | Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for medicaid programs beginning in 1993. (12 Dec 1998) |
| utilization review | An organised procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use. (12 Dec 1998) |
| utilization time | The minimum duration of a stimulus of rheobasic strength that is just sufficient to produce excitation. Synonym: temps utile. (05 Mar 2000) |
| alactic oxygen debt | That part of the oxygen debt that is not lactacid oxygen debt; during recovery, stores of ATP and creatine phosphate must be replenished by oxidative metabolism, and a small amount of oxygen is also needed to restore the normal oxyhemoglobin levels throughout the circulating blood. (05 Mar 2000) |
| alveolar-arterial oxygen difference | The difference or gradient between the partial pressure of oxygen in the alveolar spaces and the arterial blood: P(A-a)02. Normally in young adults this value is less than 20 mm Hg. See: alveolar gas equation. (05 Mar 2000) |
| arteriovenous oxygen difference | <physiology> The difference in the oxygen content (in ml per 100 ml blood) between arterial and venous blood. (05 Mar 2000) |
| biochemical oxygen demand | The amount of oxygen aerobicorganisms need to carry out oxidative metabolism in watercontaining organic matter, such as sewage. (09 Oct 1997) |
| carbon-oxygen ligases | <enzyme> Enzymes that catalyze the joining of two molecules by the formation of a carbon-oxygen bond. Registry number: EC 6.1 (12 Dec 1998) |
| carbon-oxygen lyases | <enzyme> Enzymes that catalyze the cleavage of a carbon-oxygen bond by means other than hydrolysis or oxidation. Registry number: EC 4.2 (12 Dec 1998) |
| reactive oxygen species | Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development. (12 Dec 1998) |
| chemical oxygen demand | The amount of dissolved oxygen required to combine with chemicals in wastewater. A measure of the oxygen equivalent of that portion of organic matter that is susceptible to oxidation by a strong chemical oxidizing agent. (05 Dec 1998) |
| rubredoxin-oxygen oxidoreductase | <enzyme> Contains fad and a new type of haem; site of oxygen reduction to water by desulfovibrio gigas coupled with NADH oxidation Registry number: EC 1.9.3.- Synonym: rubredoxin oxidase (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|